Lin Xu
Impact in
- Cancer Research top 0.1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Pollution top 0.2%
- Pharmaceutical and Antibiotic Environmental Impacts
Papers in
-
- Cancer-related molecular mechanisms research 49
-
- Lung Cancer Diagnosis and Treatment 68
- Lung Cancer Treatments and Mutations 57
- Tracheal and airway disorders 21
- Journals
- PLoS ONE (22 papers)Scientific Reports (10 papers)Oncotarget (10 papers)Tumor Biology (9 papers)Journal of Clinical Oncology (8 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lin Xu
458 papers receiving 15.2k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Cancer Research 4.6k
- Pollution 2.0k
- Molecular Medicine 654
- Molecular Biology 6.5k
- Oncology 2.2k
Countries citing papers authored by Lin Xu
This map shows the geographic impact of Lin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Xu more than expected).
Fields of papers citing papers by Lin Xu
This network shows the impact of papers produced by Lin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Xu. The network helps show where Lin Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 7 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 65 | |
| 12 | 2021 | 26 | |
| 13 | 2020 | 31 | |
| 14 | 4E-BP1Thr46 Phosphorylation Association with Poor Prognosis in Quantitative Phosphoproteomics of Portal Vein Tumor Thrombus Revealed that 4E-BP1Thr46 Phosphorylation is Associated with Poor Prognosis in HCC | 2020 | 1 |
| 15 | 2019 | 25 | |
| 16 | Increased expression of TMED2 is an unfavorable prognostic factor in patients with breast cancer | 2019 | 4 |
| 17 | 2018 | 215 | |
| 18 | 2018 | 61 | |
| 19 | LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1 Hit paper breakdown → | 2016 | 405 |
| 20 | 2014 | 156 |
About Lin Xu
Lin Xu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Microbiology, Oncology and Molecular Biology, having authored 476 papers that have together received 15.4k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (68 papers), RNA modifications and cancer (63 papers), Lung Cancer Treatments and Mutations (57 papers), Cancer-related molecular mechanisms research (49 papers), Esophageal Cancer Research and Treatment (26 papers), Viral Infections and Vectors (22 papers), Tracheal and airway disorders (21 papers) and Lung Cancer Research Studies (21 papers). The work is most often cited by research in Cancer Research (4.6k citations), Pollution (2.0k citations), Molecular Medicine (654 citations), Molecular Biology (6.5k citations) and Oncology (2.2k citations). Lin Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Rong Yin, Yi Luo, Mantang Qiu, Michal Rysz, Pedro J. J. Alvarez, Daqing Mao, Youtao Xu, Feng Jiang, Siwei Wang and Hongbing Shen. Their work appears in journals such as PLoS ONE, Scientific Reports, Oncotarget, Tumor Biology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.